SCHEMBL7037544

SCHEMBL7037544

BrCc1ccnc(-c2ccccn2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.54
LMNA P02545 3/20 0.54
CCR1 P32246 3/20 0.54
CCR5 P51681 3/20 0.54
CCR8 P51685 3/20 0.54
CYP1A2 P05177 1/20 0.54
POLB P06746 1/20 0.54
METAP1 P53582 1/20 0.54
BLM P54132 1/20 0.54
HIF1A Q16665 1/20 0.54
DOHH Q9BU89 1/20 0.54
P4HTM Q9NXG6 1/20 0.54
KDM6B O15054 1/20 0.47
KDM4A O75164 1/20 0.47
KDM5C P41229 1/20 0.47
KDM4C Q9H3R0 1/20 0.47
KDM2A Q9Y2K7 1/20 0.47
KDM3A Q9Y4C1 1/20 0.47
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259178 0.88 CCR1 (0.42) KDM4ELMNACCR1CCR5CCR8
SCHEMBL29871243 0.88 CCR1 (0.42) KDM4ELMNACCR1CCR5CCR8
Bromide SCHEMBL16739305 0.86 CCR1 (0.41) CCR1CCR5CCR8ALDH1A1TRPA1
SCHEMBL8585585 0.81 KDM4E (0.45) KDM4ELMNACCR1CCR5CCR8
SCHEMBL7972258 0.81 ASIC3 (0.53) KDM4ENPC1ALDH1A1HSP90AA1PIM1
SCHEMBL4535559 0.81 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL29603676 0.81 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30485802 0.81 LOXL2 (0.56) KDM4ELMNACCR1CCR5CCR8
SCHEMBL28416719 0.81 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL7036361 0.81 LOXL2 (0.56) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055477-A1 METHOD FOR THE TREATMENT OF MC RECEPTOR RELATED DISORDERS WITH A CHELATE AND/OR A CHELATOR 7TM PHARMA A/S (DK) 2003-07-10 WO disclosed
WO-2003003009-A1 USE OF METAL-ION CHELATES IN VALIDATING BIOLOGICAL MOLECULES AS DRUG TARGETS IN TEST ANIMAL MODELS 7TM PHARMA A/S (DK) 2003-01-09 WO disclosed
WO-2003003008-A1 CHEMICAL LIBRARIES USEFUL FOR DRUG DISCOVERY PROCESSES 7TM PHARMA A/S (DK) 2003-01-09 WO disclosed
US-5563273-A COLOR CHANGE AGENT INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1996-10-08 US disclosed
EP-0431547-B1 Charge transfer salts and uses thereof IBM (US) 1994-09-21 EP disclosed
US-5179467-A Color for visual displays in electrochemical cells INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1993-01-12 US disclosed
WO-1991008507-A1 CHARGE TRANSFER SALTS AND USES THEREOF INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 1991-06-13 WO disclosed
EP-0431547-A2 Charge transfer salts and uses thereof International Business Machines Corporation (US) 1991-06-12 EP disclosed